The Latest
-
Mesoblast expands compassionate use COVID-19 program
-
Xeris Spikes 12% After-Hours On Soros Stake; Analyst Says Buy
-
Ford: restrictions at Mexico plants ‘not sustainable’
-
Fed’s aggressive monetary policy behind the stock market rally